Novavax
NVAX
159 hedge funds and large institutions have $2.05B invested in Novavax in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 65 increasing their positions, 50 reducing their positions, and 23 closing their positions.
41% more capital invested
Capital invested by funds: $1.46B → $2.05B (+$596M)
30% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 50
5% less funds holding
Funds holding: 167 → 159 (-8)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
31% less call options, than puts
Call options by funds: $19M | Put options by funds: $27.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$21.6M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$13.9M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.3M |
| 5 |
Renaissance Technologies
New York
|
+$9.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.4M |
| 2 |
CNB
City National Bank
Beverly Hills,
California
|
-$8.07M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$6.12M |
| 4 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$4.58M |
| 5 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$3.89M |
NVAX Hedge Fund Activity: Q2 2015 in Review
159 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2015, worth a combined $2.05B — up 41% from $1.46B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of NVAX and 16 opened new positions — a net loss of 7 holders — while 50 trimmed existing stakes and 65 added.
The largest buyer was Vanguard Group, adding an estimated $34M. The largest seller was Susquehanna International Group, cutting an estimated $20.4M.
- 159 institutional investors held Novavax (NVAX) as of Q2 2015, down from 167 in Q1 2015.
- Funds reported $2.05B of Novavax stock for Q2 2015, up 41% quarter-over-quarter.
- 16 funds opened new Novavax positions in Q2 2015 and 23 closed out, a net change of -7 holders.
- The largest Novavax buyer in Q2 2015 was Vanguard Group, an estimated $34M added.
- The largest Novavax seller in Q2 2015 was Susquehanna International Group, an estimated $20.4M sold.
Based on aggregated 13F filings for Q2 2015.